[ Back to EurekAlert! ]

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Germline-Targeting Immunogen eOD-GT6

Caption: The researchers demonstrated their new technique by engineering a compound that has promise to initiate an otherwise rare immune response against many types of HIV. Here, the germline-targeting immunogen eOD-GT6 (red) is shown bound to its target, the germline VRC01 antibody (magenta and yellow).

Credit: Photo courtesy of The Scripps Research Institute.

Usage Restrictions: None

Related news release: New vaccine-design approach targets HIV and other fast-mutating viruses


[ Back to EurekAlert! ]